Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semiselective Immunoadsorption and Membrane Filtration for Desensitization in ABO-incompatible Kidney Transplantation - a Phase 2 Pilot Study

NCT02120482 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT02120482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02120482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semiselective Immunoadsorption and Membrane Filtration for Desensitization in ABO-incompatible Kidney Transplantation - a Phase 2 Pilot Study
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2014
Completion date
July 31, 2022
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody-mediated rejection, decreased immunologic activity